FLC
IMGN

Fifth Lane Capital’s Immunogen Inc IMGN Stock Holding History

Fifth Lane Capital’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-49,362
Closed -$1.46M – 208
2023
Q4 		$1.46M Buy
+49,362
New +$983K 1.72% 8

Other funds holding IMGN

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $10B AUM 15.14% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Fifth Lane Capital's IMGN Position: Q1 2024 in Review

Fifth Lane Capital sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 49,362 shares — an estimated $1.46M sold.

Fifth Lane Capital first reported a position in IMGN in Q4 2023 and held it in 1 quarter. The position peaked at $1.46M in Q4 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

  • Fifth Lane Capital reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
  • Fifth Lane Capital sold 49,362 Immunogen Inc shares in Q1 2024, an estimated $1.46M.
  • Fifth Lane Capital first reported a position in Immunogen Inc in Q4 2023 and held it in 1 quarter.
  • Fifth Lane Capital's Immunogen Inc position peaked at $1.46M in Q4 2023.
  • 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on Fifth Lane Capital's 13F filing for Q1 2024, filed 2 May 2024.